Skip to main content
. 2022 Dec 13:1–14. Online ahead of print. doi: 10.1007/s00467-022-05835-4

Table 2.

Summary of studies on inactivated vaccines. In the case of vaccines for Pneumococcus, only studies on conjugated vaccines (PCV) are reported

Reference Study type (N of subjects) Diagnosis pre-vaccine Type of vaccine Rec./de novo Comments
Pneumococcal
  Liakou et al. [38] Observational study (33) NS PCV7 0/0 15 patients were on low dose oral prednisolone or no therapy and 18 were receiving additional treatment of Mycophenolate mofetil or ciclosporin A for a minimum of 6 months prior to enrolment
  Liakou et al. [40] Observational study (29) NS PCV7 0/0 PCV7 was not associated with increased risk of INS relapse and serotype-specific antibodies increased in all subjects at 1 month
  Pittet et al. [39] Observational study (42) NS PCV13 0/0 Vaccination was performed at disease onset or at regular follow up, during remission
Influenza
  Kielstein et al. [43] Case report (1) Healthy Inactivated H1N1 0/1
  Poyrazoğlu et al. [48] Case series (19) NS Inactivated H1N1 0/0 The first relapse was reported in one subject at three months after vaccination
  Gutierrez et al. [44] Case report (1) Healthy Inactivated H1N1 0/1 Histology showed severe acute tubular injury and interstitial inflammatory infiltrate. The immunofluorescence was negative. Ultrastructural examination showed diffuse foot-process effacement, microvillus transformation and cytoplasmic vacuolization
  Fernandes et al. [42] Case report (1) Healthy Inactivated H1N1 0/1 Patient developed NS one week after receiving vaccine. Oral steroid therapy was started, and proteinuria returned to the non-nephrotic range
  Kutlucan et al. [45] Case report (1) Healthy Inactivated H1N1 0/1 Histological findings were consistent with membranous glomerulonephritis
  Tanaka et al. [49] Observational study (15) NS Inactivated H1N1 NA No side effects including NS were reported
  Klifa et al. [50] Monocentric retrospective investigation (14) SSNS Inactivated H1N1 0/0 Relapse rate differed but without statistical significance between vaccinated and unvaccinated subjects
  Ishimori et al. [51] Multicenter observational study (306) NS Inactivated H1N1 NA Risk of relapse was lower in vaccinated than non-vaccinated. Moreover, in vaccinated, risk of relapse was lower in post-vaccine time than in pre-vaccine time
  Kamei et al. [21] Observational Study NS Live attenuated NA Patients were receiving immunosuppression agents. Immunization resulted effective

NA not available, NS nephrotic syndrome, PCV polysaccharide vaccines, SSNS steroidsensitive nephrotic syndrome